Huaqin Technology Co., Ltd. (SHA:603296)

CTI BioPharma Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	80,594	71,918	57,861	-	-	-
Market Cap Growth	35.08%	24.30%	-	-	-	-
Enterprise Value	80,394	68,166	46,419	-	-	-
Last Close Price	79.78	70.05	55.52	-	-	-
PE Ratio	25.57	24.58	21.38	-	-	-
Forward PE	19.20	21.12	21.21	-	-	-
PS Ratio	0.63	0.66	0.68	-	-	-
PB Ratio	3.39	3.14	2.78	-	-	-
P/TBV Ratio	3.99	3.70	2.94	-	-	-
P/FCF Ratio	-	-	24.26	-	-	-
P/OCF Ratio	-	52.28	15.03	-	-	-
EV/Sales Ratio	0.62	0.62	0.54	-	-	-
EV/EBITDA Ratio	23.20	21.65	14.67	-	-	-
EV/EBIT Ratio	34.71	31.66	20.82	-	-	-
EV/FCF Ratio	-23.60	-	19.46	-	-	-
Debt / Equity Ratio	0.70	0.53	0.31	0.49	0.38	0.29
Debt / EBITDA Ratio	4.77	3.73	1.99	2.47	2.40	0.88
Debt / FCF Ratio	-	-	2.74	30.23	-	6.81
Asset Turnover	1.93	1.72	1.79	2.08	2.17	2.26
Inventory Turnover	13.81	12.61	14.38	11.90	12.14	12.47
Quick Ratio	0.86	0.83	1.07	0.86	0.76	0.93
Current Ratio	1.16	1.13	1.27	1.14	1.03	1.18
Return on Equity (ROE)	13.99%	13.31%	15.97%	22.59%	21.82%	36.89%
Return on Assets (ROA)	2.17%	2.11%	2.92%	2.30%	1.52%	5.16%
Return on Capital (ROIC)	4.35%	4.30%	6.07%	6.43%	5.10%	16.29%
Return on Capital Employed (ROCE)	7.80%	8.10%	9.70%	9.80%	8.00%	22.80%
Earnings Yield	3.92%	4.07%	4.68%	-	-	-
FCF Yield	-4.23%	-0.96%	4.12%	-	-	-
Dividend Yield	1.12%	1.29%	1.54%	-	-	-
Payout Ratio	35.06%	36.41%	6.50%	9.48%	6.41%	26.01%
Buyback Yield / Dilution	-3.74%	-6.23%	-4.45%	0.00%	-3.36%	-
Total Shareholder Return	-2.62%	-4.95%	-2.90%	0.00%	-3.36%	-

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.